Trial Profile
The efficacy of Venlafaxine in comparison with placebo in the treatment of adult with attention deficit hyperactivity disorder: A double blind randomized clinical trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Mar 2013
Price :
$35
*
At a glance
- Drugs Venlafaxine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- 18 Jan 2012 Results published in Human Psychopharmacology: Clinical and Experimental.
- 18 Jan 2012 Status changed from active, no longer recruiting to completed.
- 07 Sep 2011 New trial record